Empowering Your Downstream Cell and Gene Therapy Processes: A Sexton Biotechnologies Focus

Sexton_Model_SignataCT-5_Setup

BioLife Solutions acquired Sexton Biotechnologies to better serve the needs of cell and gene therapy (CGT) developers and manufacturers. Sexton complements BioLife’s existing portfolio by offering media to improve cell performance and cell expansion, automated and flexible fluid transfer manufacturing equipment, and modern CGT storage containers for closed-system processing. Sexton tools can advance your downstream […]

This website uses cookies to ensure you get the best experience on our website.